CTMX

Cytomx Therapeutics Inc

• TipRanks·04/02 00:12

  CytomX Therapeutics Signals Progress in Varseta-M Trial

• NASDAQ·04/01 11:56

  Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

• Dow Jones·03/23 17:01

  CytomX Therapeutics Price Target Raised to $12.00/Share From $10.00 by Piper Sandler

• Dow Jones·03/23 17:01

  CytomX Therapeutics Is Maintained at Overweight by Piper Sandler

• Benzinga·03/23 16:51

  Piper Sandler Maintains Overweight on CytomX Therapeutics, Raises Price Target to $12

• TipRanks·03/23 15:07

  3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts

• TipRanks·03/23 10:55

  CytomX Therapeutics price target raised to $12 from $10 at Piper Sandler

• Simply Wall St·03/20 16:14

  How Investors Are Reacting To CytomX Therapeutics (CTMX) Equity Raise And Encouraging Varseta-M Trial Data

• NASDAQ·03/20 14:13

  Weekly Buzz: GSK's Lynavoy Gets FDA Nod; Reproxalap Rejected Again; LNSR Ends Merger Deal

• TipRanks·03/20 02:06

  Top CytomX Executives Quietly Unload Shares in a Wave of Insider Selling

• TipRanks·03/19 20:33

  CytomX Therapeutics Raises $234 Million in Equity Offering

• Benzinga·03/19 17:05

  12 Health Care Stocks Moving In Thursday's Intraday Session

• Dow Jones·03/19 14:35

  CytomX Therapeutics Is Maintained at Overweight by Barclays

• Benzinga·03/19 14:25

  Barclays Maintains Overweight on CytomX Therapeutics, Raises Price Target to $16

• Reuters·03/19 10:37

  CYTOMX THERAPEUTICS <CTMX.O>: BARCLAYS RAISES TARGET PRICE TO $16 FROM $10